Company news

Gan & Lee Pharmaceuticals Co., Ltd. news in 2021

Gan & Lee Pharmaceuticals Co., Ltd.'s news releases, calls and decks from 2021, newest first.

View company

Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)

October 14, 2021

New Data on Phase 1 Proposed Biosimilar Gan & Lee Insulins Aspart (GL-ASP), Lispro (GL-LIS), and Glargine (GL-GLA) Presented at the American Diabetes Association's 81st Scientific Sessions

July 2, 2021